Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

43results about How to "Avoid ingestion" patented technology

Slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system, and preparation method thereof

The invention belongs to the field of biotechnology, and relates to a slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system, and a preparation method thereof. The slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system is prepared via self-assembly of a slightly acidic environment targeted polypeptide modified dendrimer encapsulated gene, wherein the surface of the dendrimer is rich of amino groups. According to the preparation method, a polypeptide of transmembrane helix protein C derived from bacteria visual purple is used for modifying a high molecular carrier, enrichment and adhesion onto cells is realized via a pH sensitive cell membrane insertion method, and entering into cells is realized via electrostatic adsorption guided endocytosis, so that untaking of tumor cells on drugs is improved, and toxic and side effects are reduced. According to the tumor targeted nano drug delivery system, cell membrane is taken as the target point, and the polypeptide is taken as the target head group in tumor slightly acidic environment, targeting and curing efficiency are high, the preparation method is simple and convenient, and tumor cell drugs, which are derived from human or animal, and is used for targeted therapy, can be prepared.
Owner:FUDAN UNIV

Establishment of self-assembly nanoparticles of redox hypersensitive disulfide bond bridged prodrug

The invention belongs to the technical field of medicine, and designs and synthesizes a series of disulfide bond-containing micromolecular prodrugs in which carbon chains in different lengths are linked (sulfur atoms in the disulfide bond are respectively located alpha, beta and gamma sites of an ester bond). PTX (Paclitaxel)-CIT (Citronellol) is used as a sample, and a synthesis method is simpleand easy. On the basis, a micromolecular prodrug self-assembly nano-drug delivery system is prepared. The preparation method is simple and convenient, the stability is high, and efficient encapsulation and delivery of drugs are realized. The invention discovers that the disulfide bond has redox dual sensitivity, can be fractured under the action of high-expression ROS (Reactive Oxygen Species) andGSH (Glutathione) of tumor cells, and PTX can be released; particularly, redox dual hypersensitivity is shown by PTX-CIT prodrugs (alpha-PTX-SS-CIT), which are located in the alpha site of a carbonylgroup, of the disulfide bond, the alpha-PTX-SS-CIT prodrugs can be quickly fractured to release the PTX and take effects, an anti-tumor effect of the PTX is remarkably improved, and a wide development prospect is obtained.
Owner:SHENYANG PHARMA UNIVERSITY

Construction of photosensitizer-hypoxia activated prodrug integrated prodrug self-assembled nanoparticles

The invention belongs to the technical field of medicines and relates to a photosensitizer-hypoxia activated prodrug integrated prodrug. According to the invention, a photosensitizer and a hypoxia activated prodrug are connected through a bond which breaks under triggering by photo-induced electron transfer, a bond sensitive to active oxygen, or a bond which breaks under the triggering by photo-induced electron transfer and is sensitive or non-sensitive to active oxygen, so the photosensitizer and the hypoxia activated prodrug can be efficiently co-loaded and synchronously delivered. Pyropheophorbide a is used as a photosensitizer, PR104A is used as a hypoxia activated prodrug, a thioketal bond or monothioether bond or non-sensitive carbonate bond is employed for connecting pyropheophorbide with PR104A to synthesize an integrated prodrug, and then a self-assembled nanometer drug delivery system is prepared. According to the invention, a preparation process is simple; the drug loading capacity of the nanoparticles is high; the particle size of the nanoparticles is small and uniform, so the nanoparticles can be enriched at a tumor part through an EPR effect; while photodynamic therapy is conducted, the selective release of the hypoxia activated prodrug in the tumor is triggered through dual modes of PET and ROS; and the photodynamic therapy promotes the activation of the hypoxiaactivated prodrug, and significantly improves the synergistic anti-tumor effect of the photosensitizer and the hypoxia activated prodrug.
Owner:SHENYANG PHARMA UNIVERSITY

Barrier-free soup-adding hot pot

The invention provides a barrier-free soup-adding hot pot, and relates to an intelligent hot pot. The intelligent hot pot comprises a table body, a heating device, a pot body, a rotating mechanism, anautomatic oil tank system, an automatic soup system, a lifting mechanism, an upper cover body and the like, wherein the table body comprises a table panel and a bottom plate; the center of the tablepanel is hollowed-out; the heating device is mounted at the hollowed-out position; the pot body is placed on the heating device; the heating device and the pot body are annular; the automatic oil tanksystem and the automatic soup system are mounted on the bottom plate; and the output end of the automatic oil tank system successively penetrates through the hollowed-out position of the table panel,the central hole of the heating device and the pot wall of the inner side of the pot body and extends to the position above a cavity of the pot body. Soup and edible oil can be added automatically, the space of the table body does not need to be occupied, the hot pot does not hinders diners, splashing can further be prevented when soup and water are added, the barrier-free soup-adding hot pot hasthe characteristics of convenience in cleaning, simplicity and attractiveness, convenience in isolation of a seasoning from food materials, stirring and clamping are facilitated, food is convenient to find, lampblack is small, degree of automation is high, the hot pot is convenient to use, and the like, and the barrier-free soup-adding hot pot is easy to popularize and use.
Owner:LUSHAN COLLEGE OF GUANGXI UNIV OF SCI & TECH

Construction of Photosensitizer-Chemotherapeutic "Photochemical Integrated" Small Molecule Prodrug and Its Self-Assembled Nanoparticles

The invention belongs to the technical field of medicines, relates to a photosensitizer-chemotherapeutic drug 'photosensitizer-chemotherapeutic integration' micromolecule prodrug, and aims to connecta chemotherapeutic drug with a photosensitizer through ester bonds or mono-thioether bonds to achieve efficient co-carrying and synchronous delivery of the chemotherapeutic drug and the photosensitizer. The photosensitizer-chemotherapeutic drug is prepared from paclitaxel as a chemotherapeutic drug and coked phaeophytin a as a photosensitizer, a self-assembled nano medicine delivery system is alsoprepared, and synergetic medicine release, in-vivo pharmacokinetics and anti-tumor effects of the drug are evaluated. The predrug is simple in preparation process, small and uniform in nanoparticle size, beneficial to enrichment of nanoparticles at tumor parts through an EPR (Enhanced Permeability and Retention) effect, super large in drug loading capacity and easy in surface modification, and reticuloendothelial system uptaking can be effectively avoided, in addition, uptaking of tumor cells upon the nanoparticles can be effectively improved; while photodynamic treatment is carried out, selective release of medicines can be synergistically triggered in tumor cells; by adopting the 'photosensitizer-chemotherapeutic integration' micromolecule prodrug self-assembled nano drug delivery system designed by the invention, the synergetic anti-tumor effects of the photosensitizer and the chemotherapeutic drug can be remarkably improved.
Owner:SHENYANG PHARMA UNIVERSITY

Construction of paclitaxel-oleic acid small molecule prodrug self-assembled nanoparticles

The invention designs and synthesizes a series of paclitaxel-oleic acid small-molecular prodrugs; with the application of a chemical connecting arm which is sensitive to an oxidation-deoxidation environment, the rapid release of the drugs in tumor cells is promoted. On the basis, small-molecular prodrug self-assembled nano-drug delivery systems are prepared. The small-molecular prodrug self-assembled nano-drug delivery systems have the advantages that by virtue of a one-step nano-precipitation method, nano-drug self-assembled nanoparticles are simple in preparation process and easy for industrialization; the nano-drug self-assembled nanoparticles are small and uniform in grain size (to 100nm), and the nano-drug self-assembled nanoparticles are enriched in a tumor part by virtue of an EPR (enhanced permeability and retention) effect; an ultrahigh drug-loading capacity is guaranteed, which is beneficial for reducing adverse reactions caused by auxiliary materials and biological materials; surface modification is easy to implement, and the intake of a reticuloendothelial system can be effectively avoided and the intake of the tumor cells to the nanoparticles can be improved by virtue of PEG (polyethylene glycol) and active targeting modification; and on the basis of the sensitivity of the chemical connecting arm to the oxidation-deoxidation microenvironment of the tumor cells, the specific drug release of paclitaxel in the tumor part is achieved, a curative effect is improved and toxic and side effects are reduced.
Owner:SHENYANG PHARMA UNIVERSITY +1

Cabazitaxel weakly-alkaline derivative and preparation thereof

The invention relates to a cabazitaxel weakly-alkaline derivative and a preparation thereof, in particular to synthesis of the cabazitaxel weakly-alkaline derivative, a liposome preparation containingthe cabazitaxel weakly-alkaline derivative and application of the cabazitaxel weakly-alkaline derivative in a drug delivery system, and belongs to the technical field of medicines. According to the cabazitaxel weakly-alkaline derivative, cabazitaxel is connected with a weakly-alkaline intermediate through an ester bond, the ester bond can be broken under the action of esterase in vivo, and an active drug is released. The structural general formula is shown in the specification, wherein a connecting group is C1-C4 alkyl, C3-C6 naphthenic base or phenyl; [N] is an N-methyl piperazinyl group, apiperidinyl group, a 4-(1-piperidinyl) piperidinyl group, a morpholinyl group, a pyrrolidine group or other tertiary amine structures. The cabazitaxel weakly-alkaline derivative disclosed by the invention can be prepared into the liposome preparation. The liposome preparation has the characteristics of high drug loading capacity, high encapsulation efficiency, good stability and the like. After injection administration, the in-vivo circulation time of the drug can be greatly prolonged, the accumulation amount of the drug at a tumor part is increased, and the anti-tumor effect and the tolerancedose are improved. .
Owner:SHENYANG PHARMA UNIVERSITY

External application Chinese medicine composition for treating hemorrhoids and preparation method thereof

The invention relates to an external application Chinese medicine composition for treating hemorrhoids. The external application Chinese medicine composition comprises the following raw materials by weight: 21-30g of sodium sulfate, 5-12g of myrrh, 11-15g of alum, 11-20g of borax and 0.5-1g of borneol. The using method is that: the raw materials are ground, are evenly mixed, are packaged in two bags and are put into a small plastic bag for closed preservation, and totally fourteen bags are prepared; one bag per time is put into a basin and is mixed with 1000ml of boiling water, fumigation is conducted first and washing is conducted thereafter for 10-30 minutes, and two times per day are required; for patients with erosion around anuses or severe hemorrhoids, moisture burn ointment is coated on the edge of the anuses after fumigation and washing, one suppository for treating hemorrhoids is inserted into the anus, and one treatment course comprises six days; after the patients use the medicine, the symptom at the anus is relieved or disappeared in 3-5 days, and the using method can be changed to one time of fumigation and washing after the symptom is relieved or disappeared to continuously consolidate the treatment for one treatment course. The medicine is used to treat 960 cases of patients with hemorrhoids in five years, the safety is proved to be high, no relapse occurs, the clinical cure rate is about 58 percent and the total effective rate is about 95 percent.
Owner:张银川
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products